Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 5—May 2009
Dispatch

Probable Congenital Babesiosis in Infant, New Jersey, USA

Sonia Sethi, David Alcid, Hemant Kesarwala, and Robert W. TolanComments to Author 
Author affiliations: The Children’s Hospital at Monmouth Medical Center, Long Branch, New Jersey, USA (S. Sethi); Saint Peter’s University Hospital, New Brunswick, New Jersey, USA (D. Alcid, H. Kesarwala, R.W. Tolan, Jr.); Robert Wood Johnson Medical School, New Brunswick (D. Alcid); Drexel University College of Medicine, Philadelphia, Pennsylvania, USA (H. Kesarwala, R.W. Tolan, Jr.)

Main Article

Table 1

Clinical and laboratory data for infant with probable congenital babesiosis*

Clinical/laboratory data Day of hospitalization
1 2 3 4 5 6 7 8
Maximum daily temperature, ºF 102.7 101.9 100.6 98.0 98.8 99.6 99.4 98.8
Hepatomegaly, cm below costal margin 4 4 4 5 Stable Stable Smaller Smaller
Splenomegaly, cm below costal margin 5 5 5 5 Stable Stable Smaller Smaller
Lowest daily hemoglobin level, g/dL 8.8 8.1 7.0† 9.8 8.6 7.4 8.5 9.6
Lowest daily platelet count, 103/mm3 34 30 23 34 45 112 185 340
Parasitemia, % 15.2 Present‡ Present‡ 2 <1 NA 0 NA
Highest daily total bilirubin level, mg/dL 5.9§ NA 3.6 3.9 2.7 2.1 1.7 1.3
Highest daily lactate dehydrogenase level, IU/L NA NA 1,912¶ 2,481 2,535 2,286 2,239 1,566
Highest daily C-reactive protein level, mg/dL 54# NA 130 82 62 39 NA NA
Treatment CRO,
ATO, AZI CRO,
ATO, AZI CRO, ATO, AZI, PRBC CRO,
ATO, AZI CRO,
ATO, AZI CRO,
ATO, AZI CRO,
ATO, AZI CRO,
ATO, AZI

*NA, not assessed; CRO, ceftriaxone sodium; ATO, atovaquone; AZI, azithromycin; PRBC, packed red blood cells.
†Before PRBC transfusion.
‡Not quantified.
§Reference range 0.1–1.2 mg/dL.
¶Reference range 313–618 IU/L.
#Reference range 1.0–10.0 mg/dL.

Main Article

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external